ecolab inc. - ECL

ECL

Close Chg Chg %
250.67 -2.17 -0.87%

Closed Market

248.50

-2.17 (0.87%)

Volume: 1.38M

Last Updated:

Nov 12, 2024, 3:59 PM EDT

Company Overview: ecolab inc. - ECL

ECL Key Data

Open

$251.10

Day Range

247.72 - 251.32

52 Week Range

177.08 - 262.61

Market Cap

$70.95B

Shares Outstanding

283.16M

Public Float

252.47M

Beta

1.14

Rev. Per Employee

N/A

P/E Ratio

35.15

EPS

$7.18

Yield

91.00%

Dividend

$0.57

EX-DIVIDEND DATE

Sep 17, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

1.01M

 

ECL Performance

1 Week
 
-0.69%
 
1 Month
 
-2.24%
 
3 Months
 
3.18%
 
1 Year
 
39.58%
 
5 Years
 
29.50%
 

ECL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 29
Full Ratings ➔

About ecolab inc. - ECL

Ecolab, Inc. engages in providing products and services in the field of water, hygiene, and energy. It operates through the following segments: Global Industrial, Global Institutional and Specialty, Global Energy and Life Science, and Other. The Global Industrial segment relates to water, food and beverage, paper, and downstream operating segments. The Global Institutional and Specialty segment refers to the institutional, specialty, and healthcare operating segments. The Global Healthcare and Life Sciences segment includes the healthcare and life sciences operations. The Other segment is involved in providing services to detect, eliminate and prevent pests. The company was founded by Merritt J. Osborn in 1923 and is headquartered in St. Paul, MN.

ECL At a Glance

Ecolab, Inc.
1 Ecolab Place
St. Paul, Minnesota 55102-2233
Phone 1-800-232-6522 Revenue 15.32B
Industry Chemicals: Specialty Net Income 1.37B
Sector Process Industries 2023 Sales Growth 7.982%
Fiscal Year-end 12 / 2024 Employees 48,000
View SEC Filings

ECL Valuation

P/E Current 35.147
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 41.41
Price to Sales Ratio 3.709
Price to Book Ratio 7.038
Price to Cash Flow Ratio 23.562
Enterprise Value to EBITDA 20.967
Enterprise Value to Sales 4.221
Total Debt to Enterprise Value 0.135

ECL Efficiency

Revenue/Employee 319,170.833
Income Per Employee 28,589.583
Receivables Turnover 5.071
Total Asset Turnover 0.707

ECL Liquidity

Current Ratio 1.299
Quick Ratio 0.954
Cash Ratio 0.212

ECL Profitability

Gross Margin 40.321
Operating Margin 14.104
Pretax Margin 11.459
Net Margin 8.957
Return on Assets 6.337
Return on Equity 17.961
Return on Total Capital 8.179
Return on Invested Capital 8.666

ECL Capital Structure

Total Debt to Total Equity 108.561
Total Debt to Total Capital 52.052
Total Debt to Total Assets 39.976
Long-Term Debt to Equity 99.157
Long-Term Debt to Total Capital 47.544
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Ecolab Inc. - ECL

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
11.79B 12.73B 14.19B 15.32B
Sales Growth
-20.90% +8.00% +11.42% +7.98%
Cost of Goods Sold (COGS) incl D&A
6.89B 7.51B 8.77B 9.14B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
812.70M 843.10M 938.70M 923.60M
Depreciation
594.30M 604.40M 618.50M 616.70M
Amortization of Intangibles
218.40M 238.70M 320.20M 306.90M
COGS Growth
-20.78% +8.98% +16.73% +4.28%
Gross Income
4.90B 5.22B 5.42B 6.18B
Gross Income Growth
-21.07% +6.61% +3.80% +13.96%
Gross Profit Margin
+41.54% +41.01% +38.20% +40.32%
2020 2021 2022 2023 5-year trend
SG&A Expense
3.19B 3.54B 3.81B 4.02B
Research & Development
185.00M 186.00M 190.00M 192.00M
Other SG&A
3.00B 3.35B 3.62B 3.82B
SGA Growth
-20.82% +10.94% +7.73% +5.40%
Other Operating Expense
- - - -
-
Unusual Expense
286.70M 155.60M 199.00M 160.10M
EBIT after Unusual Expense
1.42B 1.53B 1.41B 2.00B
Non Operating Income/Expense
(15.40M) 101.50M 196.60M 109.60M
Non-Operating Interest Income
14.60M 12.30M 8.50M 52.20M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
246.10M 216.20M 263.70M 354.70M
Interest Expense Growth
+1.36% -12.15% +21.97% +34.51%
Gross Interest Expense
246.10M 216.20M 263.70M 354.70M
Interest Capitalized
- - - -
-
Pretax Income
1.16B 1.41B 1.34B 1.76B
Pretax Income Growth
-38.84% +21.77% -5.01% +30.68%
Pretax Margin
+9.85% +11.11% +9.47% +11.46%
Income Tax
176.60M 270.20M 234.50M 362.50M
Income Tax - Current - Domestic
(43.90M) 30.90M 145.70M 137.60M
Income Tax - Current - Foreign
259.80M 240.20M 231.40M 280.00M
Income Tax - Deferred - Domestic
12.00M 3.60M (78.90M) (40.10M)
Income Tax - Deferred - Foreign
(51.30M) (4.50M) (63.70M) (15.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
984.80M 1.14B 1.11B 1.39B
Minority Interest Expense
17.40M 14.10M 17.20M 20.70M
Net Income
967.40M 1.13B 1.09B 1.37B
Net Income Growth
-37.94% +16.80% -3.38% +25.70%
Net Margin Growth
+8.21% +8.87% +7.69% +8.96%
Extraordinaries & Discontinued Operations
- - - (2.17B)
-
Discontinued Operations
- - - (2.17B)
-
Net Income After Extraordinaries
(1.21B) 1.13B 1.09B 1.37B
Preferred Dividends
- - - -
-
Net Income Available to Common
(1.21B) 1.13B 1.09B 1.37B
EPS (Basic)
-4.199 3.9466 3.8278 4.8151
EPS (Basic) Growth
-177.60% +193.99% -3.01% +25.79%
Basic Shares Outstanding
287.00M 286.30M 285.20M 285.00M
EPS (Diluted)
-4.199 3.9083 3.8091 4.7899
EPS (Diluted) Growth
-178.79% +193.08% -2.54% +25.75%
Diluted Shares Outstanding
287.00M 289.10M 286.60M 286.50M
EBITDA
2.52B 2.53B 2.55B 3.08B
EBITDA Growth
-19.99% +0.21% +0.82% +21.04%
EBITDA Margin
+21.39% +19.85% +17.96% +20.13%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 277.105
Number of Ratings 29 Current Quarters Estimate 1.807
FY Report Date 12 / 2024 Current Year's Estimate 6.654
Last Quarter’s Earnings 1.83 Median PE on CY Estimate N/A
Year Ago Earnings 5.21 Next Fiscal Year Estimate 7.507
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 23 15 24 24
Mean Estimate 1.81 1.52 6.65 7.51
High Estimates 1.84 1.65 6.70 7.80
Low Estimate 1.73 1.45 6.58 7.04
Coefficient of Variance 1.19 3.50 0.36 1.94

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 10 11 10
OVERWEIGHT 2 2 2
HOLD 16 15 15
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Ecolab Inc. - ECL

Date Name Shares Transaction Value
Jul 3, 2024 David W. MacLennan Director 17,252 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 Suzanne M. Vautrinot Director 9,372 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 Judson Althoff Director 206 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 Tracy B. McKibben Director 8,530 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 John J. Zillmer Director 45,311 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 Eric Mark Green Director 2,004 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $238.84 per share 478,635.36
Jul 3, 2024 Eric Mark Green Director 1,856 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 Shari L. Ballard Director 7,408 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $238.84 per share 1,769,326.72
Jul 3, 2024 Shari L. Ballard Director 7,250 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 David W. MacLennan Director 17,317 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $238.84 per share 4,135,992.28
Jul 3, 2024 Lionel L. Nowell Director 5,596 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 Arthur Joseph Higgins Director 25,886 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $238.84 per share 6,182,612.24
Jul 3, 2024 Arthur Joseph Higgins Director 25,690 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 Victoria J. Reich Director 24,041 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 3, 2024 Michael J. Larson Director 15,336 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 9, 2024 Victoria J. Reich Director 934 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 9, 2024 Lionel L. Nowell Director 934 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 9, 2024 Arthur Joseph Higgins Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 9, 2024 Arthur Joseph Higgins Director 25,548 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $227.52 per share 5,812,680.96
May 9, 2024 Michael J. Larson Director 934 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Ecolab Inc. in the News